Back to search

University of Thessaly (UTH)

Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές

Abstract

dc:description

Background: Cyclooxygenase-2 (Cox-2) is an important enzyme in colorectal carcinogenesis and Cox inhibitors such as aspirin (acetylsalicylic acid, ASA) have shown both Cox-2 dependent and independent anti-neoplastic activities in diverse models. The Ubiquitin-Proteasome system (UPS) is a multi-unit protease system that regulates the abundance and function of a growing number of cell proteins and its inhibition results in cancer cell growth inhibition and apoptosis and is already exploited in the clinic with the use of proteasome inhibitor bortezomib in multiple myeloma. Materials and methods: Human colorectal cancer cells lines HCT116, HT-29 and CaCo2 growing in RPMI1640 medium in the presence or absence of ASA and bortezomib were used in the experiments. MTT assay, trypan blue exclusion and DNA fragmentation were the assays used for the measurement of cell proliferation and apoptosis after drug exposure. Cox and proteasome activity were measured with a colorimetric and a fluorimetric method respectively. The expression of proteins at base line and after drug exposure was determined by western blotting. Results: Bortezomib together with aspirin inhibit the growth of colorectal cancer cell lines HCT116, HT-29 and CaCo2 more than each drug alone. In both HCT116 and HT-29 cell lines ASA inhibitory effects are Cox-2 independent because HCT116 cells do not express the enzyme while in HT-29 cells Cox-2 has no activity as shown by a Cox activity assay. In CaCo2 cells that express enzymatically active Cox-2 the extent of Cox-2-dependent and independent mechanisms in mediating anti-neoplastic activity of the drug combination remains to be determined. Cell cycle inhibitors p21 and p27 are induced in the three cell lines by bortezomib and the combination treatment. akt1 kinase is down-regulated in all three lines by the same treatments. Transcription factor NF-κB is retained in the cytoplasm by drug treatment in cell lines HCT116 and HT-29, a fact that may play a role in their pro-apoptotic activity. Pro-apoptotic bcl-2 family member, bad is down-regulated in cell lines HCT116 and CaCo2 by bortezomib treatment, a neoplasia-promoting event that is reversed by combination treatment. Conclusion: The combination of bortezomib and ASA co-operates to decrease proliferation and induce apoptosis in three human colorectal cell lines with different genetic lesions. These effects are at least in some cases Cox-2 independent and involve common and diverse mechanisms in the three lines.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Voutsadakis, Ioannis
  • Βουτσαδάκης, Ιωάννης

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17179

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Voutsadakis, Ioannis; Βουτσαδάκης, Ιωάννης. Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές. University of Thessaly (UTH), 2008. http://hdl.handle.net/10442/hedi/17179